Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression
- PMID: 19431154
- DOI: 10.1002/path.2563
Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression
Abstract
Striking similarities exist between molecular mechanisms driving embryonic liver development and progression of hepatocellular carcinoma (HCC). Bone morphogenetic proteins (BMPs), particularly BMP4, have been proposed to regulate embryonic hepatic development. BMP expression has been observed in neoplasia but the expression and biological role of BMP4 in human HCC are unknown. We found increased BMP4 mRNA and protein in HCC cell lines and tissue samples compared to primary human hepatocytes and corresponding non-tumourous tissue. Hypoxia further induced BMP4 expression in HCC cells, which was abolished by transfection of a dominant negative form of HIF-1 alpha (dnHIF-1 alpha). However, gel shift assays revealed only minor binding activity in nuclear extracts from (hypoxic) HCC cells to a putative hypoxia-response element in the BMP4 promoter. Sequence analysis of the BMP4 promoter revealed two Ets-1 binding sites, and Ets-1 activity was increased in HCC cells under hypoxic conditions. Transfection of dnHIF-1 alpha completely abrogated hypoxia-induced Ets-1 activity as well as BMP4 expression. Overexpression of Ets-1 markedly enhanced BMP4 promoter activity, while antisense Ets-1 almost completely abolished basal as well as hypoxia-induced BMP4 expression. These data demonstrate that Ets-1 activity contributes to baseline expression of the BMP4 gene and is the predominant mediator of the HIF-dependent BMP4 induction under hypoxic conditions. To determine the functional relevance of BMP4 expression, HCC cell lines were treated with antisense BMP4 constructs or siRNA against BMP4. BMP4 suppression resulted in a strong reduction of the migratory and invasive potential and anchorage-independent growth. Furthermore, tube formation assays indicated that BMP4 expressed by HCC cells promotes vasculogenesis. Our findings demonstrate that BMP4 is increased in HCC and promotes HCC progression. Therefore, BMP4 expression may have clinical relevance, and interfering with BMP4 signalling appears as an attractive therapeutic target for this highly aggressive tumour.
(c) 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Similar articles
-
Bone morphogenetic protein 4-a fascinating regulator of cancer cell behavior.Cancer Genet. 2012 Jun;205(6):267-77. doi: 10.1016/j.cancergen.2012.05.009. Cancer Genet. 2012. PMID: 22749032 Review.
-
Thyroid hormone receptors suppress pituitary tumor transforming gene 1 activity in hepatoma.Cancer Res. 2008 Mar 15;68(6):1697-706. doi: 10.1158/0008-5472.CAN-07-5492. Cancer Res. 2008. PMID: 18339849
-
Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma.J Gastroenterol Hepatol. 2007 Aug;22(8):1178-82. doi: 10.1111/j.1440-1746.2007.04997.x. Epub 2007 Jun 7. J Gastroenterol Hepatol. 2007. PMID: 17559361 Review.
-
Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration.Cancer Res. 2005 Jan 15;65(2):448-56. Cancer Res. 2005. PMID: 15695386
-
Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma.Cancer Res. 2000 Nov 15;60(22):6519-25. Cancer Res. 2000. PMID: 11103822
Cited by
-
Loss of tumor-derived SMAD4 enhances primary tumor growth but not metastasis following BMP4 signalling.Cell Commun Signal. 2024 Apr 30;22(1):248. doi: 10.1186/s12964-024-01559-0. Cell Commun Signal. 2024. PMID: 38689334 Free PMC article.
-
The benign nature and rare occurrence of cardiac myxoma as a possible consequence of the limited cardiac proliferative/ regenerative potential: a systematic review.BMC Cancer. 2023 Dec 18;23(1):1245. doi: 10.1186/s12885-023-11723-3. BMC Cancer. 2023. PMID: 38110859 Free PMC article.
-
Thymus-derived hormonal and cellular control of cancer.Front Endocrinol (Lausanne). 2023 Jul 17;14:1168186. doi: 10.3389/fendo.2023.1168186. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37529610 Free PMC article. Review.
-
Bone Morphogenetic Protein 13 Has Protumorigenic Effects on Hepatocellular Carcinoma Cells In Vitro.Int J Mol Sci. 2023 Jul 4;24(13):11059. doi: 10.3390/ijms241311059. Int J Mol Sci. 2023. PMID: 37446238 Free PMC article.
-
Distinctive modulation of hepcidin in cancer and its therapeutic relevance.Front Oncol. 2023 Feb 21;13:1141603. doi: 10.3389/fonc.2023.1141603. eCollection 2023. Front Oncol. 2023. PMID: 36895478 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous